SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Mar 7 3:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: FNS who wrote (589)3/21/1998 2:44:00 PM
From: Robohogs  Read Replies (1) of 965
 
Roche could not sell the drug to Genentech - the US FTC made them divest this drug in order to obtain US approval for Roche's acquisition. The FTC didn't want Roche effectively controlling both drugs - one directly and one through its ownership of GNE. CNTO does have a put on the drug back to Roche depending on lawsuit results. I wonder what the FTC will say if the put were exercised? Good luck all - with any luck 45 (and eventually 50 again) is on the way.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News